Review





Similar Products

90
Siemens Healthineers immulite 1000 solid-phase automated competitive binding chemiluminescent enzyme immunoassay
Immulite 1000 Solid Phase Automated Competitive Binding Chemiluminescent Enzyme Immunoassay, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/immulite 1000 solid-phase automated competitive binding chemiluminescent enzyme immunoassay/product/Siemens Healthineers
Average 90 stars, based on 1 article reviews
immulite 1000 solid-phase automated competitive binding chemiluminescent enzyme immunoassay - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Solid Phase Inc solid phase binding assay
Solid Phase Binding Assay, supplied by Solid Phase Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/solid phase binding assay/product/Solid Phase Inc
Average 90 stars, based on 1 article reviews
solid phase binding assay - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Sussex Research Laboratories solid-phase direct binding elisa assay
Solid Phase Direct Binding Elisa Assay, supplied by Sussex Research Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/solid-phase direct binding elisa assay/product/Sussex Research Laboratories
Average 90 stars, based on 1 article reviews
solid-phase direct binding elisa assay - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Diagnostic Products Corp solid-phase protein-binding radioimmunoassay
Solid Phase Protein Binding Radioimmunoassay, supplied by Diagnostic Products Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/solid-phase protein-binding radioimmunoassay/product/Diagnostic Products Corp
Average 90 stars, based on 1 article reviews
solid-phase protein-binding radioimmunoassay - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Siemens AG immulite 1000 solid-phase automated competitive binding chemiluminescent enzyme immunoassay
Immulite 1000 Solid Phase Automated Competitive Binding Chemiluminescent Enzyme Immunoassay, supplied by Siemens AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/immulite 1000 solid-phase automated competitive binding chemiluminescent enzyme immunoassay/product/Siemens AG
Average 90 stars, based on 1 article reviews
immulite 1000 solid-phase automated competitive binding chemiluminescent enzyme immunoassay - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Diasource sa solid-phase, competitive binding radioimmunoassay
Solid Phase, Competitive Binding Radioimmunoassay, supplied by Diasource sa, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/solid-phase, competitive binding radioimmunoassay/product/Diasource sa
Average 90 stars, based on 1 article reviews
solid-phase, competitive binding radioimmunoassay - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

86
Thermo Fisher binding capacity c18 solid phase extraction pipette tips
a) Experimental illustration of samples used for immunopeptidome comparison in PDAC. b) Multiplexed immunofluorescence of a representative autochthonous PDAC tumor. White arrows indicate cancer cell nests. c) High magnification multiplexed immunofluorescence image depicting the specificity of StrepTagII staining on cancer cells. d) Schematic illustration of the traditional method of peptide extraction (top) and the method used for competitive elution of MHC-I complexes with biotin used in this study (bottom). e) Immunoblot demonstrating efficient precipitation of the MHC-I heavy and light chain with acid (1% TFA) prior to peptide clean-up with <t>C18</t> ziptip. f) Representative immunoblot demonstrating purification of MHC-I specifically from KP/KbStrep tumor bearing mice. g) Number of unique peptides identified in each sample type after filtering for length (8-11 amino acids) and NetMHCPan predicted affinity (<1000 nM). h) Amino acid length distribution of all peptides identified from 2D, Ortho, Auto, or WT samples. i) Peptide motifs of 8- and 9-mers isolated from 2D, orthotopic, and autochthonous tumors. j) Venn diagram comparison of peptides found in 2D, Ortho, or Auto samples. Peptides only found in vivo are outlined in red. k) Venn diagram comparing MHC-I peptides derived from normal pancreas in Schuster et. al. (gray) versus orthotopic transplant (light blue) or autochthonous PDAC (dark blue) in this study. l) UMAP embedding of reanalyzed pancreatic scRNAseq data from the Tabula Muris. For clarity of presentation in Extended Data Figure 2m, cells from a specific lineage were collapsed into a single cluster if they originally separated into multiple clusters (i.e. Alpha 1 and Alpha 2 → Alpha). m) Expression of gene signatures derived from genes encoding for normal pancreas peptides (gray), orthotopic PDAC peptides (light blue), and autochthonous PDAC peptides (dark blue) in all cell types of the normal pancreas as measured by scRNAseq from Tabula Muris.
Binding Capacity C18 Solid Phase Extraction Pipette Tips, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/binding capacity c18 solid phase extraction pipette tips/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
binding capacity c18 solid phase extraction pipette tips - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

90
Transasia Bio Medicals Ltd solid phase competitive enzyme linked immunosorbent assay (elisa) based on the principle of competitive binding
a) Experimental illustration of samples used for immunopeptidome comparison in PDAC. b) Multiplexed immunofluorescence of a representative autochthonous PDAC tumor. White arrows indicate cancer cell nests. c) High magnification multiplexed immunofluorescence image depicting the specificity of StrepTagII staining on cancer cells. d) Schematic illustration of the traditional method of peptide extraction (top) and the method used for competitive elution of MHC-I complexes with biotin used in this study (bottom). e) Immunoblot demonstrating efficient precipitation of the MHC-I heavy and light chain with acid (1% TFA) prior to peptide clean-up with <t>C18</t> ziptip. f) Representative immunoblot demonstrating purification of MHC-I specifically from KP/KbStrep tumor bearing mice. g) Number of unique peptides identified in each sample type after filtering for length (8-11 amino acids) and NetMHCPan predicted affinity (<1000 nM). h) Amino acid length distribution of all peptides identified from 2D, Ortho, Auto, or WT samples. i) Peptide motifs of 8- and 9-mers isolated from 2D, orthotopic, and autochthonous tumors. j) Venn diagram comparison of peptides found in 2D, Ortho, or Auto samples. Peptides only found in vivo are outlined in red. k) Venn diagram comparing MHC-I peptides derived from normal pancreas in Schuster et. al. (gray) versus orthotopic transplant (light blue) or autochthonous PDAC (dark blue) in this study. l) UMAP embedding of reanalyzed pancreatic scRNAseq data from the Tabula Muris. For clarity of presentation in Extended Data Figure 2m, cells from a specific lineage were collapsed into a single cluster if they originally separated into multiple clusters (i.e. Alpha 1 and Alpha 2 → Alpha). m) Expression of gene signatures derived from genes encoding for normal pancreas peptides (gray), orthotopic PDAC peptides (light blue), and autochthonous PDAC peptides (dark blue) in all cell types of the normal pancreas as measured by scRNAseq from Tabula Muris.
Solid Phase Competitive Enzyme Linked Immunosorbent Assay (Elisa) Based On The Principle Of Competitive Binding, supplied by Transasia Bio Medicals Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/solid phase competitive enzyme linked immunosorbent assay (elisa) based on the principle of competitive binding/product/Transasia Bio Medicals Ltd
Average 90 stars, based on 1 article reviews
solid phase competitive enzyme linked immunosorbent assay (elisa) based on the principle of competitive binding - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Greiner Bio solid phase high binding 96 well plates
a) Experimental illustration of samples used for immunopeptidome comparison in PDAC. b) Multiplexed immunofluorescence of a representative autochthonous PDAC tumor. White arrows indicate cancer cell nests. c) High magnification multiplexed immunofluorescence image depicting the specificity of StrepTagII staining on cancer cells. d) Schematic illustration of the traditional method of peptide extraction (top) and the method used for competitive elution of MHC-I complexes with biotin used in this study (bottom). e) Immunoblot demonstrating efficient precipitation of the MHC-I heavy and light chain with acid (1% TFA) prior to peptide clean-up with <t>C18</t> ziptip. f) Representative immunoblot demonstrating purification of MHC-I specifically from KP/KbStrep tumor bearing mice. g) Number of unique peptides identified in each sample type after filtering for length (8-11 amino acids) and NetMHCPan predicted affinity (<1000 nM). h) Amino acid length distribution of all peptides identified from 2D, Ortho, Auto, or WT samples. i) Peptide motifs of 8- and 9-mers isolated from 2D, orthotopic, and autochthonous tumors. j) Venn diagram comparison of peptides found in 2D, Ortho, or Auto samples. Peptides only found in vivo are outlined in red. k) Venn diagram comparing MHC-I peptides derived from normal pancreas in Schuster et. al. (gray) versus orthotopic transplant (light blue) or autochthonous PDAC (dark blue) in this study. l) UMAP embedding of reanalyzed pancreatic scRNAseq data from the Tabula Muris. For clarity of presentation in Extended Data Figure 2m, cells from a specific lineage were collapsed into a single cluster if they originally separated into multiple clusters (i.e. Alpha 1 and Alpha 2 → Alpha). m) Expression of gene signatures derived from genes encoding for normal pancreas peptides (gray), orthotopic PDAC peptides (light blue), and autochthonous PDAC peptides (dark blue) in all cell types of the normal pancreas as measured by scRNAseq from Tabula Muris.
Solid Phase High Binding 96 Well Plates, supplied by Greiner Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/solid phase high binding 96 well plates/product/Greiner Bio
Average 90 stars, based on 1 article reviews
solid phase high binding 96 well plates - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Corning Life Sciences solid-phase vegfr-1 variant binding assays costar 96-well eia/ria stripwells #2592
a) Experimental illustration of samples used for immunopeptidome comparison in PDAC. b) Multiplexed immunofluorescence of a representative autochthonous PDAC tumor. White arrows indicate cancer cell nests. c) High magnification multiplexed immunofluorescence image depicting the specificity of StrepTagII staining on cancer cells. d) Schematic illustration of the traditional method of peptide extraction (top) and the method used for competitive elution of MHC-I complexes with biotin used in this study (bottom). e) Immunoblot demonstrating efficient precipitation of the MHC-I heavy and light chain with acid (1% TFA) prior to peptide clean-up with <t>C18</t> ziptip. f) Representative immunoblot demonstrating purification of MHC-I specifically from KP/KbStrep tumor bearing mice. g) Number of unique peptides identified in each sample type after filtering for length (8-11 amino acids) and NetMHCPan predicted affinity (<1000 nM). h) Amino acid length distribution of all peptides identified from 2D, Ortho, Auto, or WT samples. i) Peptide motifs of 8- and 9-mers isolated from 2D, orthotopic, and autochthonous tumors. j) Venn diagram comparison of peptides found in 2D, Ortho, or Auto samples. Peptides only found in vivo are outlined in red. k) Venn diagram comparing MHC-I peptides derived from normal pancreas in Schuster et. al. (gray) versus orthotopic transplant (light blue) or autochthonous PDAC (dark blue) in this study. l) UMAP embedding of reanalyzed pancreatic scRNAseq data from the Tabula Muris. For clarity of presentation in Extended Data Figure 2m, cells from a specific lineage were collapsed into a single cluster if they originally separated into multiple clusters (i.e. Alpha 1 and Alpha 2 → Alpha). m) Expression of gene signatures derived from genes encoding for normal pancreas peptides (gray), orthotopic PDAC peptides (light blue), and autochthonous PDAC peptides (dark blue) in all cell types of the normal pancreas as measured by scRNAseq from Tabula Muris.
Solid Phase Vegfr 1 Variant Binding Assays Costar 96 Well Eia/Ria Stripwells #2592, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/solid-phase vegfr-1 variant binding assays costar 96-well eia/ria stripwells #2592/product/Corning Life Sciences
Average 90 stars, based on 1 article reviews
solid-phase vegfr-1 variant binding assays costar 96-well eia/ria stripwells #2592 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


a) Experimental illustration of samples used for immunopeptidome comparison in PDAC. b) Multiplexed immunofluorescence of a representative autochthonous PDAC tumor. White arrows indicate cancer cell nests. c) High magnification multiplexed immunofluorescence image depicting the specificity of StrepTagII staining on cancer cells. d) Schematic illustration of the traditional method of peptide extraction (top) and the method used for competitive elution of MHC-I complexes with biotin used in this study (bottom). e) Immunoblot demonstrating efficient precipitation of the MHC-I heavy and light chain with acid (1% TFA) prior to peptide clean-up with C18 ziptip. f) Representative immunoblot demonstrating purification of MHC-I specifically from KP/KbStrep tumor bearing mice. g) Number of unique peptides identified in each sample type after filtering for length (8-11 amino acids) and NetMHCPan predicted affinity (<1000 nM). h) Amino acid length distribution of all peptides identified from 2D, Ortho, Auto, or WT samples. i) Peptide motifs of 8- and 9-mers isolated from 2D, orthotopic, and autochthonous tumors. j) Venn diagram comparison of peptides found in 2D, Ortho, or Auto samples. Peptides only found in vivo are outlined in red. k) Venn diagram comparing MHC-I peptides derived from normal pancreas in Schuster et. al. (gray) versus orthotopic transplant (light blue) or autochthonous PDAC (dark blue) in this study. l) UMAP embedding of reanalyzed pancreatic scRNAseq data from the Tabula Muris. For clarity of presentation in Extended Data Figure 2m, cells from a specific lineage were collapsed into a single cluster if they originally separated into multiple clusters (i.e. Alpha 1 and Alpha 2 → Alpha). m) Expression of gene signatures derived from genes encoding for normal pancreas peptides (gray), orthotopic PDAC peptides (light blue), and autochthonous PDAC peptides (dark blue) in all cell types of the normal pancreas as measured by scRNAseq from Tabula Muris.

Journal: Nature

Article Title: Deciphering the immunopeptidome in vivo reveals novel tumor antigens

doi: 10.1038/s41586-022-04839-2

Figure Lengend Snippet: a) Experimental illustration of samples used for immunopeptidome comparison in PDAC. b) Multiplexed immunofluorescence of a representative autochthonous PDAC tumor. White arrows indicate cancer cell nests. c) High magnification multiplexed immunofluorescence image depicting the specificity of StrepTagII staining on cancer cells. d) Schematic illustration of the traditional method of peptide extraction (top) and the method used for competitive elution of MHC-I complexes with biotin used in this study (bottom). e) Immunoblot demonstrating efficient precipitation of the MHC-I heavy and light chain with acid (1% TFA) prior to peptide clean-up with C18 ziptip. f) Representative immunoblot demonstrating purification of MHC-I specifically from KP/KbStrep tumor bearing mice. g) Number of unique peptides identified in each sample type after filtering for length (8-11 amino acids) and NetMHCPan predicted affinity (<1000 nM). h) Amino acid length distribution of all peptides identified from 2D, Ortho, Auto, or WT samples. i) Peptide motifs of 8- and 9-mers isolated from 2D, orthotopic, and autochthonous tumors. j) Venn diagram comparison of peptides found in 2D, Ortho, or Auto samples. Peptides only found in vivo are outlined in red. k) Venn diagram comparing MHC-I peptides derived from normal pancreas in Schuster et. al. (gray) versus orthotopic transplant (light blue) or autochthonous PDAC (dark blue) in this study. l) UMAP embedding of reanalyzed pancreatic scRNAseq data from the Tabula Muris. For clarity of presentation in Extended Data Figure 2m, cells from a specific lineage were collapsed into a single cluster if they originally separated into multiple clusters (i.e. Alpha 1 and Alpha 2 → Alpha). m) Expression of gene signatures derived from genes encoding for normal pancreas peptides (gray), orthotopic PDAC peptides (light blue), and autochthonous PDAC peptides (dark blue) in all cell types of the normal pancreas as measured by scRNAseq from Tabula Muris.

Article Snippet: The fluffy white precipitate was then pelleted by centrifugation at 20,000 x g for 10 min. Supernatants containing liberated MHC-I peptides were then directly aspirated into 8 ug binding capacity C18 solid phase extraction pipette tips (Pierce).

Techniques: Immunofluorescence, Staining, Western Blot, Purification, Isolation, In Vivo, Derivative Assay, Expressing